Advertisement
Many patients use medical cannabis without their mainstream health care provider's knowledge

Medical Cannabis Decisions Being Made by Users, Not Doctors

0
Substantial portion of medical cannabis users stop taking or self-adjust dosage of pharmaceuticals
Over time

CDC: Slight Hike in Prevalence of Gastroschisis Since 2006-2010

0
Prevalence higher in areas with high and medium versus low opioid prescription rates
From 2007 to 2016

Medication Treatment for Substance Abuse Up in Facilities

0
2007 to 2016 saw increase in use of medication treatment, reaching 36.1 percent in 2016
Mandated neonatal abstinence syndrome surveillance and reporting allows state health departments to quantify incidence and informs programs and services

Mandated Neonatal Abstinence Reporting Helps Quantify Cases

0
Five of six states with mandatory reporting receive case reports within 30 days of diagnosis
Use of the oral hepatoselective glucokinase activator TTP399 for type 2 diabetes does not cause hypoglycemia and has no detrimental effect on plasma lipids or liver enzymes

Oral Hepatoselective Glucokinase Activator Promising in T2DM

0
Clinically significant and sustained reduction in glycated hemoglobin was observed with TTP399
Less than half of all outpatient antibiotic prescription fills by privately insured nonelderly adults and children in the United States are appropriate or potentially appropriate

Inappropriate Antibiotic Rx Common in Privately Insured

0
Only 12.8 and 35.5 percent of fills were appropriate, potentially appropriate in outpatients
The U.S. Food and Drug Administration alerted health care providers on Thursday that the agency is investigating the use of paclitaxel-coated balloons and paclitaxel-eluting stents to treat peripheral arterial disease in the femoropopliteal artery because of a potentially increased mortality risk in the long term.

FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents

0
Investigation triggered by meta-analysis showing possible increased mortality in PAD patients at 2 years
A U.S. Food and Drug Administration advisory panel vote on whether to recommend approval of the first oral medication for type 1 diabetes ended in an 8-8 tie Thursday.

FDA Panel Has Tie Vote on New Type 1 Diabetes Drug

0
Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels
For postmenopausal women

Prevalence of Knee OA Lower With Menopausal Hormone Therapy

0
Odds ratio for knee osteoarthritis was 0.7 in MHT group versus non-MHT group in multivariable model
Ertugliflozin appears safe and effective at improving long-term glycemic control among adults with type 2 diabetes mellitus inadequately controlled on metformin

Ertugliflozin Seems Safe, Effective for Type 2 Diabetes Treatment

0
Improvements seen in HbA1c, fasting glucose, body weight, blood pressure over two years